Similar articles

• Progress in the development of oxytocin antagonists for use in preterm labor.

  Williams PD, Bock MG, Evans BE, Freidinger RM, Pettibone DJ. Williams PD, et al. Adv Exp Med Biol. 1998;449:473-9. doi: 10.1007/978-1-4615-4871-3_61. Adv Exp Med Biol. 1998. PMID: 10026841
• The role of oxytocin receptors and vasopressin V1a receptors in uterine contractions in rats: implications for tocolytic therapy with oxytocin antagonists.

  Chan WY, Wo NC, Manning M. Chan WY, et al. Am J Obstet Gynecol. 1996 Nov;175(5):1331-5. doi: 10.1016/s0002-9378(96)70050-9. Am J Obstet Gynecol. 1996. PMID: 8942510
• Comparison of vasopressin and oxytocin receptors in the rat uterus and vascular tissue.

  Anouar A, Clerget MS, Durroux T, Barberis C, Germain G. Anouar A, et al. Eur J Pharmacol. 1996 Jul 11;308(1):87-96. doi: 10.1016/0014-2999(96)00258-0. Eur J Pharmacol. 1996. PMID: 8836636
• Potential use of oxytocin and vasopressin V1a antagonists in the treatment of preterm labour and primary dysmenorrhoea.

  Akerlund M, Melin P, Maggi M. Akerlund M, et al. Adv Exp Med Biol. 1995;395:595-600. Adv Exp Med Biol. 1995. PMID: 8714023 Review.
• Oxytocin antagonists and their therapeutic use.

  Melin P. Melin P. Regul Pept. 1993 Apr 29;45(1-2):285-8. doi: 10.1016/0167-0115(93)90221-s. Regul Pept. 1993. PMID: 8390080 Review. No abstract available.